Clinical Trial Update: A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants [Phase 1]

View source ↗

Summary

A Phase 1 study completed evaluating the safety and immune responses of the GVGH altSonflex1-2-3 vaccine against Shigellosis in adults, children, and infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shigellosis

Drugs mentioned

• altSonflex1-2-3 vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diarrhoea | Phase 1 | Status: COMPLETED